Développer l'usage des médicaments biosimilaires et des médicaments hybrides substituables

This proposal aims to increase the use of biosimilar and hybrid medicines in France. These are alternatives to existing medicines that can offer cost savings and improve patient access to treatments. The measure would affect patients, healthcare providers, and the pharmaceutical industry. It seeks to encourage doctors to prescribe these alternatives and pharmacists to substitute them when appropriate.